THE BE T
Multimedia Highlights
From the CardioSource WorldNews YouTube Channel | Scan the QR code to watch the full video
Two Papers Look at TAVR vs. SAVR in
Intermediate-risk Patients
Vinod H. Thourani, MD: “For the first
time, we’re seeing a transcatheter valve
technology (the SAPIEN 3) being shown to
be superior to surgery in a propensity score
analysis. I think we need to redefine, or at
least re-think in our minds within the heart
team: ‘Are we now seeing a superior therapy
in transcatheter valve therapies?’”
Additional Important Outcomes
Improved with Biventricular Pacing:
More from BLOCK-HF
We Are Not Alone: Intestinal
Microbial Communities and the
Congested Gut in Heart Failure
Anne B. Curtis, MD: “The good news is that
for the clinical composite score, we found
a significant benefit or improvement in
patients with biventricular pacing over right
ventricular pacing throughout 2 years of
follow-up.”
W.H. Wilson Tang, MD: “There is a running
joke that we are 10% human and 90%
microbes, so there is really a huge amount
of understanding that we will need to relate
what we see at the bedside to this new
information.”
Thourani V, Kodali S, Makkar R, et al.
Lancet. 2016;387:2218-25.
Tang W. JCHF. 2016;4:228-9.
AF and Diabetes: Major Bleeding
Among Rivaroxaban Users
Consistent Benefit of Sacubitril/
Valsartan: More from PARADIGM-HF
W. Frank Peacock, MD: “We looked
at patients in the subset who were on
rivaroxaban and had diabetes and atrial
fibrillation. The reason to do this is because,
if you think about the CHAD score, the ‘D’ is
diabetes. So, as a subset, this is a big player.”
Scott Solomon, MD: “One question we get
from many of our colleagues and clinicians
is, ‘I have a patient. They have heart failure.
But they’re doing okay. They haven’t been
hospitalized in the past year or so. Why
should I think about switching their ACE
inhibitor and therapy drugs I’m very familiar
with to this new therapy?’ So [in this study]
we asked that question.”
12
CardioSource WorldNews: Interventions
NCDR®: Wide Variation in Hospital
Use of Early Catheterization for
NSTEMI
Carolina Hansen, MD: “Current guidelines
advocate for early invasive management
of non-STEMI patients. But we actually
know very little about current patterns of
angiography for non-STEMI patients in the
United States.”
July/August 2016